Genta
Berkeley Heights
About Genta
Genta is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite (gallium nitrate injection), tesetaxel, and oral gallium.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.4M
- Last round: Series Unknown (Aug 1991)
- Website: genta.com
- Phone: +1 908-286-9800
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/genta-1202504 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.